Key considerations around the decision to localize vaccine manufacture in LMIC countries

“...we will see some more LMIC manufacturers coming to market in the fairly near future, and becoming a fixture of the global vaccine supply chain in the years to come.”

Charlotte Barker, Commissioning Editor, Vaccine Insights, talks to Kristopher Howard, Managing Director/Owner, NRL Enterprise Solutions, about learnings gleaned from a career spent establishing vaccine manufacturing facilities and conducting tech transfer around the world.

Please enter your email to access content Read now